Merck KGaA (WBO:MRCK)
€ 150.4 -0.65 (-0.43%) Market Cap: 65.59 Bil Enterprise Value: 73.52 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 90/100

Q1 2022 Merck KGaA Earnings Call Transcript

May 12, 2022 / 12:00PM GMT
Release Date Price: €159.9 (-5.58%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the First Quarter 2022. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest;Belen Garijo Lopez
MERCK Kommanditgesellschaft auf Aktien - Head of IR;MERCK

Thank you very much, Kevin. A very warm welcome to this Merck Q1 2022 Results Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. I'm delighted to have here today with me Belén Garijo, CEO of the Group; as well as Marcus Kuhnert, CFO. Also joining for the Q&A part of this call are Matthias Heinzel, CEO of Life Science; Peter Guenter, CEO of Healthcare; as well as Kai Beckmann, CEO for Electronics. We would like to now run you through the key slides of this presentation, followed by a Q&A.

And with this, I'd like to directly hand over to Belén Garijo, Group CEO, in order to kick off this presentation. Over to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot